Erbe Elektromedizin GMBH v. Canady

545 F. Supp. 2d 491, 86 U.S.P.Q. 2d (BNA) 1592, 2008 U.S. Dist. LEXIS 12250, 2008 WL 471643
CourtDistrict Court, W.D. Pennsylvania
DecidedFebruary 19, 2008
DocketCivil Action 07-384
StatusPublished
Cited by8 cases

This text of 545 F. Supp. 2d 491 (Erbe Elektromedizin GMBH v. Canady) is published on Counsel Stack Legal Research, covering District Court, W.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Erbe Elektromedizin GMBH v. Canady, 545 F. Supp. 2d 491, 86 U.S.P.Q. 2d (BNA) 1592, 2008 U.S. Dist. LEXIS 12250, 2008 WL 471643 (W.D. Pa. 2008).

Opinion

MEMORANDUM OPINION

CONTI, District Judge.

In this memorandum opinion, the court considers the motion for summary judgment (Doc. No. 14) filed by plaintiffs ERBE Elektromedizin GmbH and ERBE Medical UK Limited (collectively “plaintiffs” or “ERBE”), as well as plaintiffs’ motion to dismiss (Doc. No. 15) the counterclaim asserted by defendant, Jerome Canady, M.D. (“defendant” or “Canady”) against ERBE. Plaintiffs in their complaint seek recognition of a judgment against Canady for attorneys’ fees awarded by the United Kingdom High Court of Justice, Chancery Division (the “High Court”) pursuant to the Pennsylvania Uniform Foreign Money Judgment Recognition Act (“Recognition Act”), 42 P.S. §§ 22001 et seq. Defendant in his counterclaim seeks nonrecognition of the judgment of the High Court for attorneys’ fees, and an injunction prohibiting ERBE from attempting to enforce the judgment in Pennsylvania. This court’s jurisdiction is invoked pursuant to 28 U.S.C. § 1332, because ERBE Elektromedizin GmbH is a citizen of the Federal Republic of Germany, ERBE Medical UK Limited is a citizen of the United Kingdom (the “UK”), and Jerome Canady, M.D., is a citizen of Pennsylvania. After considering the joint statement of material facts and the other submissions of the parties, and drawing all reasonable inferences in favor of defendant, the nonmoving party, the court will grant summary judgment in favor of plaintiffs, and grant ERBE’s motion to dismiss defendant’s counterclaim.

Factual Background

The present action is but a small portion of the extensive patent litigation between the parties. This court will not attempt to review exhaustively the particulars of each *493 related action, but mil give a brief synopsis to provide the appropriate perspective for this action.

In 1993, Canady applied for and was issued U.S. Patent No. 5,207,675 (“the '675 patent”), related to his development of flexible argon plasma coagulation (“APC”) probes. Def.’s statement of additional undisputed facts ¶ 1. Pursuant to the Patent Cooperation Treaty, Canady obtained European Patent (UK) No. 0595967 (the “UK Patent”) based on the '675 patent. Id. In 1996, Canady filed a patent infringement action in the United States District Court for the District of Columbia against ERBE based on the '675 patent and ERBE’s sale of flexible APC probes. Id. ¶ 5. In 1999, the district court granted ERBE’s motion for summary judgment dismissing that action. Id. ¶ 6. The district court later vacated its summary judgment order and stayed the proceedings pending outcome of ERBE’s petition with the U.S. Patent and Trademark Office (“PTO”) requesting a reexamination of the '675 patent. Id. Between 1999 and 2001, ERBE filed two additional requests for reexamination, and the PTO granted both requests. Id. In January 2003, the PTO issued its determinations rejecting ERBE’s reexamination arguments and reaffirming the '675 patent as originally issued. Id. Thereafter, the stay in the federal court action was terminated, and, in 2003, Canady and ERBE filed new motions for summary judgment. Id. Those motions were stricken in 2004, and Canady was directed to file a new response to ERBE’s 1998 summary judgment motion. Id. ERBE’s 1998 summary judgment motion was granted in July 2005, and was affirmed by the United States Court of Appeals for the Federal Circuit in 2006. Id.

On March 21, 2005, while waiting for the D.C. district court’s ruling on ERBE’s summary judgment motion, Canady brought an action (the “UK Patent Action”) in the High Court against ERBE for infringement of the UK Patent. Pl.’s statement of undisputed material facts ¶ 4 ERBE contested the validity of the UK Patent and denied that the UK Patent had been infringed. Id. ¶ 5. The High Court tried the issue of infringement in December 2005, and found in favor of ERBE. Id. ¶ 6. In conjunction with its finding, the High Court also entered an order on December 21, 2005, requiring Canady to pay ERBE the expenses and attorneys’ fees (the “costs”) incurred by them in the defense of the UK Patent Action. Id. Cana-dy appealed the High Court’s decision, and ERBE applied for interim costs pending appeal. Id. ¶ 8. The High Court awarded interim costs against Canady in the amount of £130,329.69. Id. ¶ 9. When Cana-dy failed to pay the interim costs, the United Kingdom Court of Appeal dismissed Canady’s appeal in July 2006. Id. 1f 14.

In May 2006, ERBE instituted proceedings in the UK to collect all of its costs relating to the UK Patent Action. Id. ¶ 11. Canady did not dispute the costs claimed by ERBE, and an order was entered by the Supreme Court Costs Office awarding ERBE costs of £473,182.87 in connection with the UK Patent Action, including the £130,329 in interim costs. Id. ¶ 12. After dismissal of Canady’s appeal, ERBE was awarded additional costs in connection with proceedings in the Court of Appeals in the amount of £26,703.48 and in connection with the interim costs proceeding in the • amount of £24,323.35. Id. ¶ 16.

On March 23, 2007, ERBE filed- the complaint in this action seeking recognition of the judgment against Canady for attorneys’ fees awarded by the High Court pursuant to the Recognition Act, 42 P.S. §§ 22001 et seq.

*494 Standard of Review

Federal Rule of Civil Procedure 56(c) provides that summary judgment may be granted if, drawing all inferences in favor of the nonmoving party, “the pleadings, depositions, answers to interrogatories, and admissions on file, together with the affidavits, if any, show that there is no genuine issue as to any material fact and that the moving party is entitled to a judgment as a matter of law.” Fed. R. Civ. P. 56(c). A motion for summary judgment will not be defeated by the mere existence of some disputed facts, but will be defeated when there is a genuine issue of material fact. Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 247-48, 106 S.Ct. 2505, 91 L.Ed.2d 202 (1986). In determining whether the dispute is genuine, the court’s function is not to weigh the evidence or to determine the truth of the matter, but only to determine whether the evidence of record is such that a reasonable jury could return a verdict for the nonmoving party. Id. at 249,106 S.Ct. 2505.

Discussion

ERBE seeks recognition, pursuant to the Recognition Act, 42 P.S. §§ 22001 et seq, of judgments by the High Court against Canady awarding attorneys’ fees. Section 3 of the Recognition Act provides as follows:

§ 22003. Recognition and enforcement

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Racicot v. Wiseau Studio CA2/3
California Court of Appeal, 2025
Clientron Corp. v. Devon IT, Inc.
35 F. Supp. 3d 665 (E.D. Pennsylvania, 2014)
Louis Dreyfus Commodities Suisse SA v. Financial Software Systems, Inc.
99 A.3d 79 (Superior Court of Pennsylvania, 2014)
Java Oil Ltd. v. Sullivan
168 Cal. App. 4th 1178 (California Court of Appeal, 2008)
Olympus Corp. v. Canady
962 A.2d 671 (Superior Court of Pennsylvania, 2008)
Novae Corporate Underwriting Ltd. v. Atlantic Mutual Insurance
556 F. Supp. 2d 489 (E.D. Pennsylvania, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
545 F. Supp. 2d 491, 86 U.S.P.Q. 2d (BNA) 1592, 2008 U.S. Dist. LEXIS 12250, 2008 WL 471643, Counsel Stack Legal Research, https://law.counselstack.com/opinion/erbe-elektromedizin-gmbh-v-canady-pawd-2008.